CA2451842A1 - Chewable product including active ingredient - Google Patents

Chewable product including active ingredient Download PDF

Info

Publication number
CA2451842A1
CA2451842A1 CA002451842A CA2451842A CA2451842A1 CA 2451842 A1 CA2451842 A1 CA 2451842A1 CA 002451842 A CA002451842 A CA 002451842A CA 2451842 A CA2451842 A CA 2451842A CA 2451842 A1 CA2451842 A1 CA 2451842A1
Authority
CA
Canada
Prior art keywords
active ingredient
product including
including active
chewable product
center
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002451842A
Other languages
French (fr)
Other versions
CA2451842C (en
Inventor
Donald Seielstad
Henry Tyrpin
Kevin Broderick
James Maxwell
David Record
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WM Wrigley Jr Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/681,935 external-priority patent/US6613346B2/en
Application filed by Individual filed Critical Individual
Publication of CA2451842A1 publication Critical patent/CA2451842A1/en
Application granted granted Critical
Publication of CA2451842C publication Critical patent/CA2451842C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums

Abstract

Products and methods of delivering medicaments are provided. The product includes a consumable center and a compressible powder that is compressed around the center. The powder includes a medicament that may or may not be encapsulated.
CA002451842A 2001-06-28 2002-06-25 Chewable product including active ingredient Expired - Fee Related CA2451842C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/681,935 US6613346B2 (en) 2001-06-28 2001-06-28 Chewable product including active ingredient
US09/681,935 2001-06-28
US10/050,470 2002-01-15
US10/050,470 US6602518B2 (en) 2001-06-28 2002-01-15 Chewable product including active ingredient
PCT/US2002/020038 WO2003002099A1 (en) 2001-06-28 2002-06-25 Chewable product including active ingredient

Publications (2)

Publication Number Publication Date
CA2451842A1 true CA2451842A1 (en) 2003-01-09
CA2451842C CA2451842C (en) 2008-09-09

Family

ID=26728300

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002451842A Expired - Fee Related CA2451842C (en) 2001-06-28 2002-06-25 Chewable product including active ingredient

Country Status (4)

Country Link
US (1) US6602518B2 (en)
EP (1) EP1406595A1 (en)
CA (1) CA2451842C (en)
WO (1) WO2003002099A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012116445A1 (en) * 2011-02-28 2012-09-07 Technologies Khlôros Inc. Chewable vehicle for mouth absorption

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627233B1 (en) * 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US6838098B2 (en) * 2000-09-07 2005-01-04 Cadbury Adams Usa, Llc Continuous formation of center filled gum
US6623266B2 (en) * 2001-01-19 2003-09-23 Cadbury Adams Usa Llc Apparatus for making a center-filled gum lollipop with hard candy shell
EP1287745A1 (en) 2001-08-24 2003-03-05 The Procter & Gamble Company Chewable compositions with probiotic agents
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US7067150B2 (en) 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
DK1803444T3 (en) 2002-12-20 2019-02-25 Niconovum Ab PROCEDURE FOR PREPARING A NICOTIC PARTICULATE MATERIAL WITH A CRYSTALLINE CELLULOSE (ESPECIALLY MCC)
US6982098B1 (en) * 2003-05-30 2006-01-03 Fun Unlimited Inc. Nutritional weight loss agent and method
US20050086225A1 (en) * 2003-10-15 2005-04-21 Xiaoming Cheng Apparatus and method for searching a directory of stored items
GB0326492D0 (en) * 2003-11-14 2003-12-17 Cadbury Schweppes Plc Liquid-filled confectionery compositions
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
BRPI0508335B1 (en) * 2004-02-26 2019-09-03 Wrigley W M Jun Co sweets and chewing gum containing physiological cooling agents
US20060286201A1 (en) * 2004-08-25 2006-12-21 Cadbury Adams Usa Llc. Multi-modality functional ingredients in chewing gum compositions
EP1796485B1 (en) * 2004-08-25 2015-10-21 Intercontinental Great Brands LLC Liquid-filled chewing gum composition
US20060280835A1 (en) * 2004-08-25 2006-12-14 Cadbury Adams Usa Llc. Multi-modality flavored chewing gum compositions
US20070148286A1 (en) * 2004-08-25 2007-06-28 Cadbury Adams Usa Llc. Liquid-filled chewing gum composition
US7727565B2 (en) * 2004-08-25 2010-06-01 Cadbury Adams Usa Llc Liquid-filled chewing gum composition
US20060263475A1 (en) * 2004-08-25 2006-11-23 Cadbury Adams Usa, Llc. Center-filled chewing gum composition
US20070148284A1 (en) * 2004-08-25 2007-06-28 Cadbury Adams Usa Llc. Liquid-filled chewing gum
US20060280834A1 (en) * 2004-08-25 2006-12-14 Cadbury Adams Usa, Llc. Center-filled chewing gum composition
US20060280836A1 (en) * 2004-08-25 2006-12-14 Cadbury Adams Usa Llc. Multi-modality tastes in chewing gum compositions
US7641926B2 (en) * 2004-08-25 2010-01-05 Cadbury Adams Usa, Llc Liquid-filled chewing gum composition
US20060153949A1 (en) * 2005-01-11 2006-07-13 Cadbury Adams Usa Llc. Edible compositions containing swellable polymers
FR2883179B1 (en) * 2005-03-18 2009-04-17 Ethypharm Sa COATED TABLET
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP1998748B1 (en) 2006-03-16 2015-01-14 NicoNovum AB Improved snuff composition
AU2007235359B2 (en) 2006-04-05 2011-03-10 Intercontinental Great Brands Llc Calcium phosphate complex and salts in oral delivery systems
PL2001452T3 (en) 2006-04-05 2017-02-28 Intercontinental Great Brands Llc Calcium phosphate complex in acid containing chewing gum
BRPI0713879A2 (en) 2006-06-29 2012-11-06 Cadbury Adams Usa Llc streamlined chain cutter for forming gum-filled pieces in the center
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20080207593A1 (en) * 2007-02-28 2008-08-28 Collegium Pharmaceutical, Inc. Antihistamine Combination
IL183818A0 (en) * 2007-06-10 2007-10-31 Shimon Harpaz Uniformly abrasive confectionery product and process therefor
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
EP2187758B2 (en) * 2007-07-27 2021-11-24 Intercontinental Great Brands LLC Method and apparatus for processing confectionery products
CN101861145A (en) * 2007-09-18 2010-10-13 尼科诺瓦姆股份公司 Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
WO2009065102A1 (en) * 2007-11-16 2009-05-22 Cadbury Adams Usa Llc Confectionery compositions including markings for delivery of actives
EP2229156B1 (en) * 2007-12-20 2016-11-09 Fertin Pharma A/S Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet
ES2564056T3 (en) * 2008-09-05 2016-03-17 Johnson & Johnson Consumer Inc. Method of making cetirizine tablets
CA2736531C (en) * 2008-09-17 2016-10-25 Niconovum Ab Process for preparing snuff composition
MX2011011506A (en) 2009-04-28 2012-05-08 Proteus Biomedical Inc Highly reliable ingestible event markers and methods for using the same.
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
UA109424C2 (en) * 2009-12-02 2015-08-25 PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS
KR20170121299A (en) 2010-04-07 2017-11-01 프로테우스 디지털 헬스, 인코포레이티드 Miniature ingestible device
JP2014504902A (en) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド Ingestible device with medicinal product
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
DE102011115173A1 (en) * 2011-08-12 2013-02-14 Ipc Process-Center Gmbh & Co. Kg Granule, useful as hot or cold drink, comprises caffeine and sucralose and Stevia/steviol glycoside and/or neohesperidin dihydrochalcone in an enclosed shell of a fat
WO2014120669A1 (en) 2013-01-29 2014-08-07 Proteus Digital Health, Inc. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
EP3639828B8 (en) 2013-12-24 2022-01-05 Virginia Commonwealth University Use of oxygenated cholesterol sulfates (ocs) for treating acute liver failure
WO2016130830A1 (en) 2015-02-11 2016-08-18 The Fix, Llc Compositions and methods for combination ingredient delivery
WO2016164464A1 (en) 2015-04-07 2016-10-13 Church & Dwight Co., Inc. Multicomponent gummy compositions with hard core
US9949499B2 (en) 2015-06-02 2018-04-24 Pet Pill Pal Llc Handheld concealed pill morsel former
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
CN109843149B (en) 2016-07-22 2020-07-07 普罗秋斯数字健康公司 Electromagnetic sensing and detection of ingestible event markers
CN109963499B (en) 2016-10-26 2022-02-25 大冢制药株式会社 Method for manufacturing capsules with ingestible event markers
CN107596107B (en) * 2017-10-11 2021-02-02 广西昌弘制药有限公司 Heat-clearing, sore-throat-relieving and anti-allergic traditional Chinese medicine preparation and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911934A (en) * 1986-12-19 1990-03-27 Warner-Lambert Company Chewing gum composition with encapsulated sweetener having extended flavor release
US5665406A (en) * 1992-03-23 1997-09-09 Wm. Wrigley Jr. Company Polyol coated chewing gum having improved shelf life and method of making
US5536511A (en) * 1994-05-06 1996-07-16 Wm. Wrigley Jr. Company Chewing gum pellet coated with a hard coating containing erythritol and xylitol
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6355265B1 (en) * 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6322806B1 (en) * 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6645535B2 (en) * 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012116445A1 (en) * 2011-02-28 2012-09-07 Technologies Khlôros Inc. Chewable vehicle for mouth absorption
AU2012222825B2 (en) * 2011-02-28 2016-01-21 Technologies Khloros Inc. Chewable vehicle for mouth absorption
US10111831B2 (en) 2011-02-28 2018-10-30 Technologies Khloros Inc. Chewable vehicle for mouth absorption

Also Published As

Publication number Publication date
US20030086960A1 (en) 2003-05-08
EP1406595A1 (en) 2004-04-14
CA2451842C (en) 2008-09-09
US6602518B2 (en) 2003-08-05
WO2003002099A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
CA2451842A1 (en) Chewable product including active ingredient
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
IL220888A0 (en) 3,10 and 12 a substituted tetracyline compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
WO2003011204A3 (en) Drug delivery systems
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
CA2311450A1 (en) Pharmaceutical aerosol compositions
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
IL163866A0 (en) 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient
PL376154A1 (en) Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
IL131163A (en) Heteroaryl-hexanoic acid amide derivatives, their use in the preparation of medicaments, and pharmaceutical compositions comprising them
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
HK1067626A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
CA2461517A1 (en) Nicotine formulations comprising cocoa and use thereof
MXPA03008420A (en) Solid orally-dispersible pharmaceutical formulation.
SG91270A1 (en) Sustained release formulation
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
IL158412A0 (en) A method for increasing the compactability of an active ingredient and a process for producing a solid dosage form having a high active ingredient drug load
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU2080695A (en) Pharmaceutical inhalation compositions containing a solid active ingredient
HUP0104238A2 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
AU2023801A (en) Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed